Both in Pharmaceuticals
CytomX Therapeutics vs Faeth Therapeutics
Over the past year CTMX returned −33.7% and FTH returned −47.5%; their daily moves had a correlation of 0.58.
CTMX −33.7% FTH −47.5%Growth of $1, one year, split-adjusted
| Metric | CTMX | FTH |
|---|---|---|
| Price | $2.18 | $19.65 |
| Market cap | $475.0M | $507.8M |
| Today | −2.24% | +2.18% |
| 1 month | −15.5% | −27.5% |
| 6 months | −46.6% | — |
| Year to date | −48.8% | — |
| 1 year | −38.9% | — |
| Revenue growth (YoY) | −92.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −1457.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 26.0× | — |
| Net cash | $330.3M | $186.4M |
| Dividend yield | — | — |
| Volatility (60d) | 67.6% | — |
| Short % of float | 21.4% | 20.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).